FDA OTC Drugs Of Abuse Screening Kit Guide Clarifies Cost Bundling
This article was originally published in The Tan Sheet
Executive Summary
FDA does not advise that OTC device manufacturers bundle the cost of primary and confirmation tests for home-use drugs of abuse test kits, the agency states in a draft guidance published in the Federal Register Dec. 2
You may also be interested in...
OTC Drugs-Of-Abuse Assay Firms Should Provide Confirmatory Testing - Panel
FDA should require manufacturers of OTC screening tests for drugs-of-abuse to cover the cost of confirmatory testing for presumptive positive results, members of FDA's Clinical Chemistry & Clinical Toxicology Devices panel recommended.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands